Explained: India close to 1st Covid vaccine; what it may cost, how it’s made | Hindustan Times
close_game
close_game

Explained: India close to 1st Covid vaccine; what it may cost, how it’s made

India has taken a crucial step towards approving a vaccine for Covid-19. A committee of experts assessing coronavirus vaccines recommended that the candidate developed by University of Oxford and AstraZeneca and manufactured in India by Serum Institute of India be cleared. The Recommendations of the Subject Expert Committee of the Central Drugs Standard Control Organisation are now being assessed by the Drugs Controller General of India. It is likely to heed to the advice of the expert committee and issue a formal approval soon. As many as 300 million people will be immunised till July in the first vaccination drive. This includes health care workers, frontline workers, elderly and those with comorbidities. The expert panel did not recommend the India-made Bharat Biotech vaccine. It has asked the firm to expedite clinical trials and sought more details. Watch the full video for more.

 
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, May 22, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On